Bispidine - One chelator to bind lutetium-177 and actinium-225

被引:0
|
作者
Bruehlmann, Santiago [1 ]
Kubeil, Manja [1 ]
Cieslik, Patrick [2 ]
Kopp, Ina [1 ]
Bachmann, Michael [1 ]
Kopka, Klaus [1 ]
Holger, Stephan [1 ]
Comba, Peter [3 ]
机构
[1] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany
[2] Univ Zurich, Zurich, Switzerland
[3] Heidelberg Univ, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P-267
引用
收藏
页码:S251 / S251
页数:1
相关论文
共 23 条
  • [1] Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225
    Cieslik, Patrick
    Kubeil, Manja
    Zarschler, Kristof
    Ullrich, Martin
    Brandt, Florian
    Anger, Karl
    Wadepohl, Hubert
    Kopka, Klaus
    Bachmann, Michael
    Pietzsch, Jens
    Stephan, Holger
    Comba, Peter
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (47) : 21555 - 21567
  • [2] Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma
    Giri, Sabeena
    Allen, Kevin J. H.
    Prabaharan, Chandra Bose
    Ramirez, Jonathan Bonet
    Fiore, Luciano
    Uppalapati, Maruti
    Dadachova, Ekaterina
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 134
  • [3] Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
    Catherine Meyer
    Vikas Prasad
    Andreea Stuparu
    Peter Kletting
    Gerhard Glatting
    Jonathan Miksch
    Christoph Solbach
    Katharina Lueckerath
    Lea Nyiranshuti
    Shaojun Zhu
    Johannes Czernin
    Ambros J. Beer
    Roger Slavik
    Jeremie Calais
    Magnus Dahlbom
    EJNMMI Research, 12
  • [4] Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
    Meyer, Catherine
    Prasad, Vikas
    Stuparu, Andreea
    Kletting, Peter
    Glatting, Gerhard
    Miksch, Jonathan
    Solbach, Christoph
    Lueckerath, Katharina
    Nyiranshuti, Lea
    Zhu, Shaojun
    Czernin, Johannes
    Beer, Ambros J.
    Slavik, Roger
    Calais, Jeremie
    Dahlbom, Magnus
    EJNMMI RESEARCH, 2022, 12 (01)
  • [6] Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-213/203 Radionuclides
    Morgan, Katherine A.
    Rudd, Stacey E.
    Noor, Asif
    Donnelly, Paul S.
    CHEMICAL REVIEWS, 2023, 123 (20) : 12004 - 12035
  • [7] Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and Functions
    Sodji, Quaovi H.
    Forsberg, Matthew H.
    Cappabianca, Dan
    Kerr, Caroline P.
    Sarko, Lauren
    Shea, Amanda
    Adam, David P.
    Eickhoff, Jens C.
    Ong, Irene M.
    Hernandez, Reinier
    Weichert, Jamey
    Bednarz, Bryan P.
    Saha, Krishanu
    Sondel, Paul M.
    Capitini, Christian M.
    Morris, Zachary S.
    CANCERS, 2024, 16 (01)
  • [8] Radiolabeling of ramucirumab with lutetium-177: The influence of chelator type on radiochemical and binding parameters
    Janousek, J.
    Barta, P.
    Trejtnar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S664 - S665
  • [9] H2BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy
    Kadassery, Karthika J.
    King, A. Paden
    Fayn, Stanley
    Baidoo, Kwamena E.
    MacMillan, Samantha N.
    Escorcia, Freddy E.
    Wilson, Justin J.
    BIOCONJUGATE CHEMISTRY, 2022, 33 (06) : 1222 - 1231
  • [10] Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of 225Ac-crown-αMSH Peptide
    Yang, Hua
    Zhang, Chengcheng
    Yuan, Zheliang
    Rodriguez-Rodriguez, Cristina
    Robertson, Andrew
    Radchenko, Valery
    Perron, Randy
    Gendron, Denise
    Causey, Patrick
    Gao, Feng
    Benard, Francois
    Schaffer, Paul
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (50) : 11435 - 11440